To study alternative bilirubin clearance pathways in vivo, we used a mouse strain with genetically induced hyperbilirubinemia due to a null mutation in the Ugt1a1 gene [29,30]. The gene discussed is UGT1A1; the disease is Hyperbilirubinemia.